CRISPR Therapeutics AG (CRSP) Gained 5.39% or 2.84 To Price $55.57 On Monday


CRISPR Therapeutics AG (CRSP) gained 5.39% or 2.84 to $55.57. It is around 1.67 million shares traded, which is 140.05% compare to the average total volume 1.19 million. The market cap of CRSP is $2.62 billion. The year to date change is 109.5%. The 52 week price range is from $13.5 to $61.24. Price of CRSP have changed 1.95% during last week. It have changed 1.85% over last month, 31.46% over last 3 months, 197.07% over last 6 months N/A

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CRSP is 50.22. It is -9.63% below current price. The 200-day Moving Averages for CRSP is 30.24. It is -45.58% below current price. The 52-week High is 61.24. It is 10.20% from the current price. The 52-week Low is 13.5. It is -75.71% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CRSP is 2.02 on 2018-04-30. Short % to float is 5.65%. There are some statistics of CRSP. It is has market cap $2.62 billion. The share outstanding is 47.19 million. The average volume is 1.19 million. The revenue is 5.97M. The percent of top 15 Institution holding is 51.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CRSP is -27.88%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CRSP is -20.12%.


Tags:

Share this post